Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spero Therapeutics, Inc. has filed 506 SEC EDGAR filings since 21 Mar 2017

SEC filing history

Showing 451-475 of 506 matching filings.

Per page
25
Current page
19
SC 13G File 005-90168

SC 13G

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90168

SC 13G

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90168

SC 13G filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Feb 2018
Reporting date
01 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
01 Feb 2018
Reporting date
01 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
23 Jan 2018
Reporting date
17 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2018
Reporting date
04 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
05 Jan 2018
Reporting date
04 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Dec 2017
Reporting date
13 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Dec 2017
Reporting date
13 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Dec 2017
Reporting date
13 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Dec 2017
Reporting date
13 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-222060

FORM S-8

Filing date
14 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
14 Dec 2017
Reporting date
14 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90168

SC 13D filing

Filing date
16 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90168

SC 13G filing

Filing date
15 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90168

THE SCHEDULE 13G

Filing date
09 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

FORM 8-K

Filing date
06 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .